Early Clinical Trial Data Show Gene Therapy Reversing Sickle Cell Anemia

Newswise imageAfter over a decade of preclinical research and development, a new gene therapy treatment for Sickle Cell Anemia (SCA) is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the world where SCA is most common.

Source link

Related posts

Eggs and Heart Disease; ADHD and Psychosis: It's PodMed Double T! (with audio)


High-Versus Low-Dose Aspirin in the Treatment of Kawasaki Disease


Breast Abscess Sequelae


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World